| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/06/2002 | WO2002068462A2 Internal standard for electrophoretic and chromatographic separation processes |
| 09/06/2002 | WO2002068453A2 Methods and compositions for the construction and use of fusion libraries using computational protein design methods |
| 09/06/2002 | WO2002068451A2 Sperm protein 17 for the diagnosis and treatment of cancer |
| 09/06/2002 | WO2002068450A2 Plasma phospholipid transfer protein (pltp) deficiency represents an anti-atherogenic state and pltp inhibitor has anti-atherosclerosis action |
| 09/06/2002 | WO2002068444A1 Ttk in diagnosis and as a therapeutic target in cancer |
| 09/06/2002 | WO2002068427A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds |
| 09/06/2002 | WO2002068386A2 Tools and methods for identifying ppar$g(d)-specific agonists and antagonists |
| 09/06/2002 | WO2002068120A2 Container for reagents for the analysis by various analytical methods, method for producing a measuring vessel, measuring vessel and use of said measuring vessel |
| 09/06/2002 | WO2002067984A2 Materials and methods for detecting, preventing, and treating hiv and fiv retroviral infection |
| 09/06/2002 | WO2002067970A1 TRYPTOPHANYL-tRNA SYNTHETASE DERIVED POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 09/06/2002 | WO2002067958A1 Method for determining efficacy of reverse cholesterol transport enhancing agents |
| 09/06/2002 | WO2002067956A2 Method for purifying a biological composition |
| 09/06/2002 | WO2002067857A2 Modified annexin proteins and methods for preventing thrombosis |
| 09/06/2002 | WO2002067771A2 Chemokine receptors and disease |
| 09/06/2002 | WO2002067766A2 Methods and material for evaluating cardiovascular conditions |
| 09/06/2002 | WO2002067764A2 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 09/06/2002 | WO2002067760A2 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 09/06/2002 | WO2002067668A1 Schizophrenia-like mental disease model animal, method of constructing the same and use thereof |
| 09/06/2002 | WO2002055089A3 Immunoassay technique using multispecific molecules |
| 09/06/2002 | WO2002048674A3 Methods, devices, arrays and kits for detecting and analyzing biomolecules |
| 09/06/2002 | WO2002048182A3 Interferon-alpha induced gene |
| 09/06/2002 | WO2002046415A9 Polynucleotide and polypeptide sequences of putative transporters and ion channells |
| 09/06/2002 | WO2002046216A3 Human sprouty-4 polypeptide |
| 09/06/2002 | WO2002040517A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002040037A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002039121A3 Methods for detecting the efficacy of anticancer treatments |
| 09/06/2002 | WO2002036632A8 Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides |
| 09/06/2002 | WO2002033732A3 Sensors comprising a semi-conductive polymer |
| 09/06/2002 | WO2002031482A3 Device and method for electrically accelerated immobilisation of molecules |
| 09/06/2002 | WO2002031182A3 Method and apparatus for reading reporter labeled beads |
| 09/06/2002 | WO2002029405A3 Method for testing substances that have a lytic effect, system for carrying out and using said method |
| 09/06/2002 | WO2002026377A3 Method and apparatus for processing biomolecule arrays |
| 09/06/2002 | WO2002026112A3 Indirect calorimetry system |
| 09/06/2002 | WO2002025269A3 Integrated optical flow cytometer with wave guide excitation |
| 09/06/2002 | WO2002020842A8 System, method and apparatus for transgenic and targeted mutagenesis screening |
| 09/06/2002 | WO2002016947A3 Methods and kits for separation and detection of proteins in biological samples |
| 09/06/2002 | WO2002016574A3 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 09/06/2002 | WO2002012901A3 Use of grf1 protein for screening molecules |
| 09/06/2002 | WO2002010217A3 Endothelial cell expression patterns |
| 09/06/2002 | WO2002008449A3 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/06/2002 | WO2002004672A3 Diagnostic method for the identification of foetal dna in a maternal sample |
| 09/06/2002 | WO2002002150A3 Stable radioiodine conjugates and methods for their synthesis |
| 09/06/2002 | WO2001096602A3 Methods and materials to determine the p53 status of a sample by determining the binding of p53 to a vector |
| 09/06/2002 | WO2001092565A3 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 09/06/2002 | WO2001092562A3 Inhibiting retroviral integration by targeting the atm pathway |
| 09/06/2002 | WO2001092479A3 Method to determine the differentiation potential of a target cell |
| 09/06/2002 | WO2001085785A3 Ph domain-interacting protein |
| 09/06/2002 | WO2001079287A3 Steatosis-modulating factors and uses thereof |
| 09/06/2002 | WO2001072995A3 Methods of producing a library and methods of selecting polynucletides |
| 09/06/2002 | WO2001072822B1 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/06/2002 | WO2001062965A3 Differential expression screening method |
| 09/06/2002 | WO2001058915A8 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 09/06/2002 | WO2001049687A9 Cyclohexene nucleic acids |
| 09/06/2002 | WO2001048485A9 Selecting library members capable of binding to epitopes |
| 09/06/2002 | WO2001031021A9 Multiple sclerosis-related superantigen |
| 09/06/2002 | WO2001024681A9 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
| 09/06/2002 | WO2001018546A9 Screening for inhibitors of 'paired helical filaments' |
| 09/06/2002 | WO2001018524A9 Methods for improving signal detection from an array |
| 09/06/2002 | WO2001018035A9 Muc-1 derived peptides |
| 09/06/2002 | WO2001016642A9 Integrated opto-electronic wavelength converter assembly |
| 09/06/2002 | WO2001014852A9 Aquatic passive sampling device and methods for its use |
| 09/06/2002 | WO2001014581A9 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 09/06/2002 | WO2001012674A9 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 09/06/2002 | WO2001012170A3 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 09/06/2002 | WO2001009608A9 Methods for simultaneously detecting both members of a binding pair |
| 09/06/2002 | WO2001009591A9 Method for optical excitation of fluorophore marked dna and rna |
| 09/06/2002 | WO2001005944A9 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 09/06/2002 | WO2000078955A9 Epithelial cell growth inhibitors |
| 09/06/2002 | WO2000065062A9 Genome sequence and polypeptides of pyrococcus abissy, fragment and uses thereof |
| 09/06/2002 | CA2846761A1 Enzymes having dehalogenase activity and methods of use thereof |
| 09/06/2002 | CA2477043A1 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | CA2444493A1 Method for identifying biologically active structures of microbial pathogens |
| 09/06/2002 | CA2440740A1 Hla ligand database utilizing predictive algorithms and methods of making and using same |
| 09/06/2002 | CA2439559A1 Method to determine prognosis after therapy for prostate cancer |
| 09/06/2002 | CA2439481A1 Method of analyzing polymer by using laser abrasion and system therefor |
| 09/06/2002 | CA2439400A1 Non-oligomerizing tandem fluorescent proteins |
| 09/06/2002 | CA2439332A1 Diagnostic test for the detection of chromosomal abnormalities in a fetus |
| 09/06/2002 | CA2439307A1 Methods for providing extended dynamic range in analyte assays |
| 09/06/2002 | CA2439303A1 Methods for identifying peptides which modulate a biological process |
| 09/06/2002 | CA2439279A1 Chemokine receptors and disease |
| 09/06/2002 | CA2439175A1 Opiate receptors |
| 09/06/2002 | CA2439134A1 Reagent for ante-mortem screening of ntac |
| 09/06/2002 | CA2439132A1 Method for determining pharmaceutically active substances |
| 09/06/2002 | CA2438923A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/06/2002 | CA2438899A1 Method for determining efficacy of reverse cholesterol transport enhancing agents |
| 09/06/2002 | CA2438757A1 Determining cartilage degeneration and aging using bone morphogenic proteins |
| 09/06/2002 | CA2438680A1 Genes encoding proteolytic enzymes from aspargilli |
| 09/06/2002 | CA2438652A1 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
| 09/06/2002 | CA2438406A1 Materials and methods for the induction of premature chromosome condensation |
| 09/06/2002 | CA2438273A1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis |
| 09/06/2002 | CA2438212A1 Biosensor for detecting chemical agents |
| 09/06/2002 | CA2437898A1 Interferon-alpha induced gene |
| 09/06/2002 | CA2435848A1 Method for purifying a biological composition |
| 09/06/2002 | CA2434727A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds |
| 09/06/2002 | CA2434690A1 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | CA2432029A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | CA2430192A1 Enzymes having dehalogenase activity and methods of use thereof |
| 09/06/2002 | CA2405878A1 Liquid flow and control in a biological test array |
| 09/06/2002 | CA2362784A1 Methods for producing protein domains and analyzing three dimensional structures of proteins by using said domains |
| 09/05/2002 | US20020124275 Generating genetically engineered worms; obtain worms, transform worms, monitor gene expression |